表紙
市場調查報告書

血液分析設備及試劑的全球市場:5分類、6分類、3分類、PoC、半自動血液分析設備 - 至2025年的預測

Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), End User (Government labs) - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 940619
出版日期 內容資訊 英文 215 Pages
訂單完成後即時交付
價格
血液分析設備及試劑的全球市場:5分類、6分類、3分類、PoC、半自動血液分析設備 - 至2025年的預測 Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), End User (Government labs) - Global Forecast to 2025
出版日期: 2020年06月01日內容資訊: 英文 215 Pages
簡介

全球血液分析設備及試劑市場預測將從2020年的76億美元,到2025年達到106億美元,年複合成長率預測將為6.9%。血液分析設備及試劑的技術進步,流式細胞技術和血液分析設備的整合,及血液疾病的發生率增加,成為調查期間中的市場促進因素。但,新興國家的血液分析設備的高成本性,產品的回收,先進的血液檢查裝置的採用延遲等要素,預計某種程度抑制這個市場成長。

本報告提供全球血液分析設備及試劑市場相關調查,市場概要,各產品、服務,終端用戶,價格分佈,應用,使用類型,及各地區的市場分析與預測,競爭情形分析,並提供主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 血液分析設備及試劑市場概要
  • 血液分析設備及試劑市場:各產品、服務
  • 血液分析設備及試劑市場:各終端用戶
  • 血液分析設備及試劑市場地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 產業趨勢
    • 成長的試劑出租商務

第6章 血液分析設備及試劑市場:各產品、服務

  • 簡介
  • 血液產品、服務
    • 試劑、消耗品
    • 設備
    • 服務
  • 止血產品、服務
  • 免疫血液產品、服務

第7章 血液分析設備及試劑市場:各種價格

  • 簡介
  • 低階血液分析設備
    • 由於容許量率低和準確度低,阻礙這個市場區隔的市場成長
  • 高階血液分析設備
    • 高階分析設備,提供可靠性,高精度,彈性,可用性等優點
  • 中階血液分析設備
    • 與高階分析儀比較,中階血液分析設備的低成本性:重要的成長要素

第8章 血液分析設備及試劑市場:各應用領域

  • 簡介
  • 出血症狀
  • 感染疾病相關疾病
  • 免疫系統相關疾病
  • 血液癌症
  • 貧血
  • 其他的用途

第9章 血液分析設備及試劑市場:各使用類型

  • 簡介
  • 獨立式分析設備
  • 照護現場分析設備

第10章 血液分析設備及試劑:各終端用戶

  • 簡介
  • 商業服務供應商
  • 醫院檢驗室
  • 政府參考檢驗室
  • 研究、學術機構

第11章 血液分析設備及試劑市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 其他南美國家
  • 中東、非洲

第12章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第13章 企業簡介概要

  • ROCHE
  • ABBOTT LABORATORIES
  • DANAHER CORPORATION
  • DIATRON
  • DREW SCIENTIFIC GROUP
  • SIEMENS HEALTHINEERS GROUP
  • SYSMEX CORPORATION
  • BIO-RAD LABORATORIES
  • HORIBA
  • 日本光電
  • EKF DIAGNOSTICS
  • BOULE DIAGNOSTICS AB
  • MINDRAY
  • BIOSYSTEMS S.A. (A GINPER GROUP COMPANY)
  • ORTHO CLINICAL DIAGNOSTICS
  • VITAL DIAGNOSTICS
  • ACCUREX BIOMEDICAL PVT. LTD.
  • CAROLINA LIQUID CHEMISTRIES
  • NEOMEDICA BIOSCIENCE TECHNOLOGY

第14章 附錄

目錄
Product Code: MD 2479

"The hematology analyzers and reagents market is projected to grow at a CAGR of 6.9%."

The global hematology analyzers and reagents market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%. Technological advancements in hematology analyzers and reagents, the integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.

"High-end hematology analyzers to be the fastest-growing segment during the forecast period."

By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The lower cost of these analyzers, in comparison with high-end analyzers, is a key factor driving the adoption of these instruments. Moreover, the smaller development, validation, and launch period for mid-range hematology analyzers (approximately two years) also contribute to overall market growth. As a result, several leading players are focused on the development of innovative technologies for mid-range hematology analyzers in the market

"The Asia Pacific is expected to grow at the highest CAGR during the forecast period."

The Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population and the resultant growth in the incidence of thalassemia, sickle-cell anemia, and leukemia. Moreover, the improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantations; and the growing number of ongoing research activities are other factors also contributing to the high growth of this segment.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
  • By Designation: C-level (23%), Director-level (30%), and Others (47%)
  • By Region: North America (40%), Europe (30%), APAC (22%), LATAM (6%), and the MEA (2%).

The major players in the hematology analyzers and reagents market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland) among others.

Research Coverage

This report studies the hematology analyzers and reagents market based on products & services; the hematology products & services market is further categorized on the basis of price range, end user, and region. The report studies the factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the five key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report focuses on various levels of analysis- market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the hematology analyzers and reagents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MAJOR MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 PROCEDURE-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
  • 4.2 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE
  • 4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
  • 4.4 GEOGRAPHIC SNAPSHOT OF THE HEMATOLOGY ANALYZERS AND REAGENTS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of blood donations
      • 5.2.1.2 Increasing incidence of blood disorders
      • 5.2.1.3 Technological advancements
      • 5.2.1.4 Integration of hematology analyzers with flow cytometry
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of advanced hematology analyzers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing use of automated hematology analyzers and increasing market penetration opportunities in emerging countries
      • 5.2.3.2 Rising awareness among end users about advanced hematology analyzers
      • 5.2.3.3 Emergence of microfluidics
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent and time-consuming regulatory process
      • 5.2.4.2 Dearth of skilled professionals in emerging economies
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 GROWING REAGENT RENTAL BUSINESS

6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 HEMATOLOGY PRODUCTS & SERVICES
    • 6.2.1 REAGENTS & CONSUMABLES
      • 6.2.1.1 Hematology reagents
        • 6.2.1.1.1 Growing preference for reagent rental business models to boost the adoption of hematology reagents
      • 6.2.1.2 Consumables
        • 6.2.1.2.1 Consumables are reusable, inexpensive, and required in limited quantities-factors supporting their adoption
      • 6.2.1.3 Controls & calibrators
        • 6.2.1.3.1 Controls & calibrators offer the highest quality of lab results, have long-term stability, and are convenient to use
      • 6.2.1.4 Slide stainers/makers
        • 6.2.1.4.1 Automated slide stainers/makers help laboratories provide cost-efficient, reliable, and uniform staining results
    • 6.2.2 INSTRUMENTS
      • 6.2.2.1 5-part and 6-part fully automated hematology analyzers
        • 6.2.2.1.1 Growing preference for 5-part and 6-part hematology analyzers due to their advantages to drive market growth
      • 6.2.2.2 3-part fully automated hematology analyzers
        • 6.2.2.2.1 3-part analyzers offer reduced maintenance costs, making them ideal cost-effective solutions for developing countries
      • 6.2.2.3 Point-of-care testing hematology analyzers
        • 6.2.2.3.1 Rising inclination towards home testing of blood levels will lead to market growth
      • 6.2.2.4 Semi-automated hematology analyzers
        • 6.2.2.4.1 Need for manual interruption will limit the adoption of these products
    • 6.2.3 SERVICES
      • 6.2.3.1 High adoption of hematology diagnostic techniques will aid market growth
  • 6.3 HEMOSTASIS PRODUCTS & SERVICES
    • 6.3.1 REAGENTS & CONSUMABLES
      • 6.3.1.1 Rising prevalence of coagulation disorders to support growth
    • 6.3.2 INSTRUMENTS
      • 6.3.2.1 Hemostasis instruments offer outstanding productivity while reducing complexities and increasing output
    • 6.3.3 SERVICES
      • 6.3.3.1 Advancements in hemostasis diagnostic techniques will accelerate market growth
  • 6.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
    • 6.4.1 REAGENTS & CONSUMABLES
      • 6.4.1.1 Development of novel immunohematology reagents is supporting market growth
    • 6.4.2 INSTRUMENTS
      • 6.4.2.1 Growing automation in immunohematology labs to boost market growth
    • 6.4.3 SERVICES
      • 6.4.3.1 Services enable customer-focused care-a key factor driving market growth

7 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE

  • 7.1 INTRODUCTION
  • 7.2 LOW-END HEMATOLOGY ANALYZERS
    • 7.2.1 LOWER THROUGHPUT RATES AND REDUCED ACCURACY WILL HAMPER THE MARKET GROWTH IN THIS SEGMENT
  • 7.3 HIGH-END HEMATOLOGY ANALYZERS
    • 7.3.1 HIGH-END ANALYZERS OFFER ADVANTAGES SUCH AS RELIABILITY, HIGH ACCURACY, FLEXIBILITY, AND EASE OF USE
  • 7.4 MID-RANGE HEMATOLOGY ANALYZERS
    • 7.4.1 LOWER COST OF MID-RANGE HEMATOLOGY ANALYZERS IN COMPARISON WITH HIGH-END ANALYZERS-A KEY GROWTH DRIVER

8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 HEMORRHAGIC CONDITIONS
    • 8.2.1 INCREASE IN HEMORRHAGIC CASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
  • 8.3 INFECTION-RELATED CONDITIONS
    • 8.3.1 GROWING BURDEN OF INFECTIOUS DISEASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
  • 8.4 IMMUNE SYSTEM-RELATED CONDITIONS
    • 8.4.1 RISING USE IN POINT-OF-CARE APPLICATIONS IS LIKELY TO AID THE ADOPTION OF HEMATOLOGY ANALYZERS & REAGENTS
  • 8.5 BLOOD CANCER
    • 8.5.1 HEMATOLOGY ANALYZERS ARE KEY INSTRUMENTS USED FOR THE DETERMINATION OF HEMATOLOGICAL MALIGNANCIES
  • 8.6 ANEMIA
    • 8.6.1 GROWING INCIDENCE OF ANEMIA TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
  • 8.7 OTHER APPLICATIONS

9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE

  • 9.1 INTRODUCTION
  • 9.2 STANDALONE ANALYZERS
    • 9.2.1 INCREASED USE OF STANDALONE ANALYZERS IN HOSPITALS AND REFERENCE LABS TO DRIVE MARKET GROWTH
  • 9.3 POINT-OF-CARE ANALYZERS
    • 9.3.1 SMALL SAMPLE REQUIREMENT LEADING TO INCREASED PREFERENCE FOR POC ANALYZERS AMONG END USERS

10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 COMMERCIAL SERVICE PROVIDERS
    • 10.2.1 GROWING OUTSOURCING WILL INCREASE THE MARKET GROWTH IN THIS SEGMENT
  • 10.3 HOSPITAL LABORATORIES
    • 10.3.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
  • 10.4 GOVERNMENT REFERENCE LABORATORIES
    • 10.4.1 AFFORDABILITY AND PROVISION OF FREE SERVICES ARE LIKELY TO PROPEL THE GROWTH OF THIS END-USER SEGMENT
  • 10.5 RESEARCH & ACADEMIC INSTITUTES
    • 10.5.1 INCREASING NUMBER OF DRUG DISCOVERY AND RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH

11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Favorable research scenario will drive market growth in the US
    • 11.2.2 CANADA
      • 11.2.2.1 Rising demand for blood and blood components to support market growth
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Increasing number of anemic patients is a major factor driving the growth of the hematology analyzers and reagents market in Germany
    • 11.3.2 UK
      • 11.3.2.1 Government support to develop innovative diagnostic technologies contributing to market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Presence of proper protocols and guidelines in diagnostics to propel market growth in the coming years
    • 11.3.4 ITALY
      • 11.3.4.1 Increasing preference for hematology testing during transplantation will result in market growth
    • 11.3.5 SPAIN
      • 11.3.5.1 Consolidation of laboratories in Spain will drive market growth
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Government initiatives and improving healthcare infrastructure to aid growth
    • 11.4.2 JAPAN
      • 11.4.2.1 Rising prevalence of flu in Japan in recent years is contributing to market growth
    • 11.4.3 INDIA
      • 11.4.3.1 High burden of chronic diseases to support market growth
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Rising prevalence of celiac disease to support the use of hematology analyzers and reagents
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Rising healthcare spending will support market growth
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Investments by leading hematology analyzer and reagent manufacturers in the country to drive market growth
    • 11.5.2 MEXICO
      • 11.5.2.1 Rising prevalence of diabetes and cancer to support market growth in Mexico
    • 11.5.3 REST OF LATAM
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MEA WILL HOLD A SMALLER SHARE AND GROW AT A LOWER RATE THAN THE MAJOR REGIONAL MARKETS

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 MARKET SHARE ANALYSIS
  • 12.3 COMPETITIVE SCENARIO
    • 12.3.1 PRODUCT LAUNCHES & APPROVALS
    • 12.3.2 PARTNERSHIPS & COLLABORATIONS
    • 12.3.3 MERGERS & ACQUISITIONS
    • 12.3.4 MARKET EXPANSIONS
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 VISIONARY LEADERS
    • 12.4.2 INNOVATORS
    • 12.4.3 DYNAMIC DIFFERENTIATORS
    • 12.4.4 EMERGING COMPANIES

13 COMPANY PROFILES (Business Overview, Products/Services Offered, Recent Developments, SWOT Analysis, and MnM View)*

  • 13.1 ROCHE
  • 13.2 ABBOTT LABORATORIES
  • 13.3 DANAHER CORPORATION
  • 13.4 DIATRON
  • 13.5 DREW SCIENTIFIC GROUP
  • 13.6 SIEMENS HEALTHINEERS GROUP
  • 13.7 SYSMEX CORPORATION
  • 13.8 BIO-RAD LABORATORIES
  • 13.9 HORIBA
  • 13.10 NIHON KOHDEN
  • 13.11 EKF DIAGNOSTICS
  • 13.12 BOULE DIAGNOSTICS AB
  • 13.13 MINDRAY
  • 13.14 BIOSYSTEMS S.A. (A GINPER GROUP COMPANY)
  • 13.15 ORTHO CLINICAL DIAGNOSTICS
  • Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
  • 13.16 DRUCKER DIAGNOSTICS
  • 13.17 VITAL DIAGNOSTICS
  • 13.18 ACCUREX BIOMEDICAL PVT. LTD.
  • 13.19 CAROLINA LIQUID CHEMISTRIES
  • 13.20 NEOMEDICA BIOSCIENCE TECHNOLOGY

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 50
  • TABLE 2 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 51
  • TABLE 3 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 51
  • TABLE 4 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 51
  • TABLE 5 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 52
  • TABLE 6 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 52
  • TABLE 7 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 53
  • TABLE 8 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION) 53
  • TABLE 9 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 54
  • TABLE 10 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 54
  • TABLE 11 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 54
  • TABLE 12 HEMATOLOGY REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 55
  • TABLE 13 HEMATOLOGY CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION) 56
  • TABLE 14 HEMATOLOGY CONTROLS & CALIBRATORS MARKET, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 15 HEMATOLOGY SLIDE STAINERS/MAKERS MARKET, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 16 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 58
  • TABLE 17 HEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 58
  • TABLE 18 HEMATOLOGY INSTRUMENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 59
  • TABLE 19 HEMATOLOGY INSTRUMENTS MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 59
  • TABLE 20 HEMATOLOGY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 59
  • TABLE 21 5-PART AND 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 61
  • TABLE 22 3-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 62
  • TABLE 23 POINT-OF-CARE TESTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 63
  • TABLE 24 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 64
  • TABLE 25 HEMATOLOGY SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 64
  • TABLE 26 HEMATOLOGY SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 65
  • TABLE 27 HEMATOLOGY SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 65
  • TABLE 28 HEMATOLOGY SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 65
  • TABLE 29 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 66
  • TABLE 30 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 66
  • TABLE 31 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 67
  • TABLE 32 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 67
  • TABLE 33 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 67
  • TABLE 34 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION) 68
  • TABLE 35 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 68
  • TABLE 36 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 69
  • TABLE 37 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 69
  • TABLE 38 HEMOSTASIS INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 70
  • TABLE 39 HEMOSTASIS INSTRUMENTS MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 70
  • TABLE 40 HEMOSTASIS INSTRUMENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 70
  • TABLE 41 HEMOSTASIS INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 71
  • TABLE 42 HEMOSTASIS SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 71
  • TABLE 43 HEMOSTASIS SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 72
  • TABLE 44 HEMOSTASIS SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 72
  • TABLE 45 HEMOSTASIS SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 72
  • TABLE 46 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 73
  • TABLE 47 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 73
  • TABLE 48 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 74
  • TABLE 49 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 74
  • TABLE 50 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 74
  • TABLE 51 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION) 75
  • TABLE 52 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 75
  • TABLE 53 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 76
  • TABLE 54 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 76
  • TABLE 55 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 77
  • TABLE 56 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 77
  • TABLE 57 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 78
  • TABLE 58 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 78
  • TABLE 59 IMMUNOHEMATOLOGY SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 79
  • TABLE 60 IMMUNOHEMATOLOGY SERVICES MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 79
  • TABLE 61 IMMUNOHEMATOLOGY SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 79
  • TABLE 62 IMMUNOHEMATOLOGY SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 80
  • TABLE 63 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 82
  • TABLE 64 LOW-END HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 83
  • TABLE 65 HIGH-END HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 84
  • TABLE 66 MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 85
  • TABLE 67 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 87
  • TABLE 68 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HEMORRHAGIC CONDITIONS, BY REGION, 2018-2025 (USD MILLION) 88
  • TABLE 69 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR INFECTION-RELATED CONDITIONS, BY REGION, 2018-2025 (USD MILLION) 89
  • TABLE 70 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR IMMUNE SYSTEM-RELATED CONDITIONS, BY REGION, 2018-2025 (USD MILLION) 90
  • TABLE 71 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR BLOOD CANCER, BY REGION, 2018-2025 (USD MILLION) 91
  • TABLE 72 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR ANEMIA, BY REGION, 2018-2025 (USD MILLION) 92
  • TABLE 73 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 92
  • TABLE 74 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2018-2025 (USD MILLION) 94
  • TABLE 75 STANDALONE HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018-2025 (USD MILLION) 95
  • TABLE 76 POINT-OF-CARE HEMATOLOGY ANALYZERS, BY REGION, 2018-2025 (USD MILLION) 96
  • TABLE 77 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 98
  • TABLE 78 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2018-2025 (USD MILLION) 99
  • TABLE 79 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2018-2025 (USD MILLION) 100
  • TABLE 80 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2018-2025 (USD MILLION) 101
  • TABLE 81 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2025 (USD MILLION) 101
  • TABLE 82 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 103
  • TABLE 83 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 105
  • TABLE 84 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 105
  • TABLE 85 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 105
  • TABLE 86 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 106
  • TABLE 87 NORTH AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 106
  • TABLE 88 NORTH AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 106
  • TABLE 89 NORTH AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 107
  • TABLE 90 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 107
  • TABLE 91 NORTH AMERICA: HEMATOLOGY ANALYZERS & REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 107
  • TABLE 92 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 108
  • TABLE 93 US: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 109
  • TABLE 94 US: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 109
  • TABLE 95 US: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 109
  • TABLE 96 US: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 110
  • TABLE 97 CANADA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 111
  • TABLE 98 CANADA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 111
  • TABLE 99 CANADA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 111
  • TABLE 100 CANADA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 112
  • TABLE 101 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 112
  • TABLE 102 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 113
  • TABLE 103 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 113
  • TABLE 104 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 113
  • TABLE 105 EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 114
  • TABLE 106 EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 114
  • TABLE 107 EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 114
  • TABLE 108 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 115
  • TABLE 109 EUROPE: HEMATOLOGY ANALYZERS & REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 115
  • TABLE 110 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 115
  • TABLE 111 GERMANY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 116
  • TABLE 112 GERMANY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 117
  • TABLE 113 GERMANY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 117
  • TABLE 114 GERMANY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 117
  • TABLE 115 UK: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 118
  • TABLE 116 UK: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 119
  • TABLE 117 UK: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 119
  • TABLE 118 UK: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 119
  • TABLE 119 FRANCE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 120
  • TABLE 120 FRANCE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 121 FRANCE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 122 FRANCE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 123 ITALY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 122
  • TABLE 124 ITALY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 122
  • TABLE 125 ITALY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 123
  • TABLE 126 ITALY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 123
  • TABLE 127 SPAIN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 124
  • TABLE 128 SPAIN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 124
  • TABLE 129 SPAIN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 124
  • TABLE 130 SPAIN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 125
  • TABLE 131 ROE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 125
  • TABLE 132 ROE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 126
  • TABLE 133 ROE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 126
  • TABLE 134 ROE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 126
  • TABLE 135 APAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 129
  • TABLE 136 APAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 129
  • TABLE 137 APAC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 129
  • TABLE 138 APAC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 130
  • TABLE 139 APAC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 130
  • TABLE 140 APAC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 130
  • TABLE 141 APAC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 131
  • TABLE 142 APAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 131
  • TABLE 143 APAC: HEMATOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 131
  • TABLE 144 APAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 132
  • TABLE 145 CHINA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 133
  • TABLE 146 CHINA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 133
  • TABLE 147 CHINA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 133
  • TABLE 148 CHINA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 134
  • TABLE 149 JAPAN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 134
  • TABLE 150 JAPAN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 135
  • TABLE 151 JAPAN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 135
  • TABLE 152 JAPAN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 135
  • TABLE 153 INDIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 136
  • TABLE 154 INDIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 137
  • TABLE 155 INDIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 137
  • TABLE 156 INDIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 137
  • TABLE 157 AUSTRALIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 138
  • TABLE 158 AUSTRALIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 138
  • TABLE 159 AUSTRALIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 139
  • TABLE 160 AUSTRALIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 139
  • TABLE 161 SOUTH KOREA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 140
  • TABLE 162 SOUTH KOREA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 140
  • TABLE 163 SOUTH KOREA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 140
  • TABLE 164 SOUTH KOREA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 141
  • TABLE 165 ROAPAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 141
  • TABLE 166 ROAPAC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 142
  • TABLE 167 ROAPAC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 142
  • TABLE 168 ROAPAC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 142
  • TABLE 169 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 143
  • TABLE 170 LATAM: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 143
  • TABLE 171 LATAM: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 144
  • TABLE 172 LATAM: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 144
  • TABLE 173 LATAM: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 144
  • TABLE 174 LATAM: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 145
  • TABLE 175 LATAM: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 145
  • TABLE 176 LATAM: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 145
  • TABLE 177 LATAM: HEMATOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 146
  • TABLE 178 LATAM: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 146
  • TABLE 179 BRAZIL: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 147
  • TABLE 180 BRAZIL: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 147
  • TABLE 181 BRAZIL: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 148
  • TABLE 182 BRAZIL: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 148
  • TABLE 183 MEXICO: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 149
  • TABLE 184 MEXICO: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 149
  • TABLE 185 MEXICO: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 149
  • TABLE 186 MEXICO: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 150
  • TABLE 187 ROLATAM: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 150
  • TABLE 188 ROLATAM: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 151
  • TABLE 189 ROLATAM: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 151
  • TABLE 190 ROLATAM: HEMATOLOGY ANALYZERS & REAGENTS MARKET, BY APPLICATION (USD MILLION) 151
  • TABLE 191 MEA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 152
  • TABLE 192 MEA: HEMATOLOGY PRODUCT & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 153
  • TABLE 193 MEA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION) 153
  • TABLE 194 MEA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION) 153
  • TABLE 195 MEA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 154
  • TABLE 196 MEA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 154
  • TABLE 197 MEA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2018-2025 (USD MILLION) 154
  • TABLE 198 MEA: HEMATOLOGY ANALYZERS & REAGENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 155
  • TABLE 199 MEA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2018-2025 (USD MILLION) 155

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN 25
  • FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET 29
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 30
  • FIGURE 4 MARKET SIZE ESTIMATION: HEMATOLOGY ANALYZERS AND REAGENTS MARKET 31
  • FIGURE 5 DATA TRIANGULATION 33
  • FIGURE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET SHARE, BY PRODUCT & SERVICE, 2020 VS. 2025 35
  • FIGURE 7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 36
  • FIGURE 8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2020 VS. 2025 (USD MILLION) 36
  • FIGURE 9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2020 VS. 2025 (USD MILLION) 37
  • FIGURE 10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 38
  • FIGURE 11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL SNAPSHOT 39
  • FIGURE 12 INCREASING NUMBER OF BLOOD DONATIONS TO DRIVE MARKET GROWTH 40
  • FIGURE 13 HEMATOLOGY PRODUCTS & SERVICES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 40
  • FIGURE 14 COMMERCIAL SERVICE PROVIDERS TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD 41
  • FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 41
  • FIGURE 16 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
  • FIGURE 17 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT 104
  • FIGURE 18 APAC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT 128
  • FIGURE 19 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE HEMATOLOGY ANALYZERS AND REAGENTS MARKET, 2016-2019 156
  • FIGURE 20 HEMATOLOGY ANALYZERS AND REAGENTS MARKET SHARE, BY KEY PLAYER, 2018 157
  • FIGURE 21 HEMATOLOGY ANALYZERS AND REAGENTS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 161
  • FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 162
  • FIGURE 23 ABBOTT LABORATORIES: COMPANY SNAPSHOT 164
  • FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT 167
  • FIGURE 25 SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT 173
  • FIGURE 26 SYSMEX CORPORATION: COMPANY SNAPSHOT 176
  • FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 181
  • FIGURE 28 HORIBA: COMPANY SNAPSHOT 183
  • FIGURE 29 NIHON KOHDEN: COMPANY SNAPSHOT 187
  • FIGURE 30 EKF DIAGNOSTICS: COMPANY SNAPSHOT 190
  • FIGURE 31 BOULE DIAGNOSTICS: COMPANY SNAPSHOT 192